TELHEMIQ Trademark
TELHEMIQ is a USPTO trademark filed by Elixirgen Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | TELHEMIQ |
|---|---|
| Serial Number | 99649326 |
| Status | Pending |
| Filing Date | 2026-02-12 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Elixirgen Therapeutics, Inc. |
| Attorney of Record | Leonard D. Bowersox |
| Prosecution Events | 3 |
| Latest Event | MAFR on 2026-02-12 |
Goods & Services
Class 005: Pharmaceutical preparations and substances for the treatment of blood disorders; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders, and blood-based diseases; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders and blood-based diseases and to be infused to a human subject; pharmaceutical preparations for cell and gene therapy for the treatment of bone marrow; pharmaceutical preparations containing cells treated with vectors encoding proteins for elongating telomeres in blood cells; pharmaceutical preparations containing blood cells treated with vectors encoding ZSCAN4 proteins for elongating telomeres in the blood cells; pharmaceutical preparations containing blood cells treated with Sendai virus vectors encoding proteins for elongating telomeres in the blood cells